Identification of the Core Structure of Lysozyme Amyloid Fibrils by Proteolysis

Journal of Molecular Biology

Volumn 361, Issue 3, 2006, Pages 551-561

  Frare, Erica ^a   Mossuto, Maria F ^a   Polverino de Laureto, Patrizia ^a   Dumoulin, Mireille ^b   Dobson, Christopher M ^b   Fontana, Angelo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

amyloid fibrils; electron microscopy; FTIR spectroscopy; limited proteolysis; lysozyme

Indexed keywords

AMYLOID; LYSOZYME; PEPSIN A; PROTEIN; PROTEINASE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; ELECTRON MICROSCOPY; INFRARED SPECTROSCOPY; PH; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN STRUCTURE; STATISTICAL SIGNIFICANCE;

EID: 33746365408     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.06.055     Document Type: Article

References (91)

1. Kelly J.W. Alternative conformations of amyloidogenic proteins govern their behavior. Curr. Opin. Struct. Biol. 6 (1996) 11-17
2. Wetzel R. For protein misassembly, it's the "I" decade. Cell 6 (1996) 699-702
3. Lansbury Jr. P.T. Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc. Natl Acad. Sci. USA 96 (1999) 3342-3344
4. Merlini G., and Bellotti V. Molecular mechanisms of amyloidosis. N. Engl. J. Med. 349 (2003) 583-596
5. Stefani M., and Dobson C.M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 81 (2003) 678-699
6. Selkoe D.J. Folding proteins in fatal ways. Nature 426 (2003) 900-904
7. Koo E.H., Lansbury Jr. P.T., and Kelly J.W. Amyloid diseases: abnormal protein aggregation in neurodegeneration. Proc. Natl Acad. Sci. USA 96 (1999) 9989-9990
8. Westermark P., Benson M.D., Buxbaum J.N., Cohen A.S., Frangione B., Ikeda S., et al. Amyloid fibril protein nomenclature. Amyloid 9 (2002) 197-200
9. Cooper J.H. Selective staining as a function of amyloid composition and structure: histochemical analysis of the alkaline Congo Red, standardized toluidine blue and iodine methods. Lab. Invest. 31 (1974) 232-238
10. LeVine H. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2 (1993) 404-410
11. Guijarro J.I., Sunde M., Jones J.A., Campbell I.D., and Dobson C.M. Amyloid fibril formation by an SH3 domain. Proc. Natl Acad. Sci. USA 95 (1998) 4224-4228
12. Chiti F., Webster P., Taddei N., Clark A., Stefani M., Ramponi G., and Dobson C.M. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl Acad. Sci. USA 96 (1999) 3590-3594
13. Dobson C.M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 24 (1999) 329-332
14. Pepys M.B., Hawkins P.N., Booth D.R., Vigushin D.M., Tennent G.A., Soutar A.K., et al. Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 362 (1993) 553-557
15. Valleix S., Drunat S., Philit J.B., Adoue D., Piette J.C., Droz D., et al. Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family. Kidney Int. 61 (2002) 907-912
16. Yazaki M., Farrell S.A., and Benson M.D. A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis. Kidney Int. 63 (2003) 1652-1657
17. Merlini G., and Bellotti V. Lysozyme: A paradigmatic molecule for the investigation of protein structure, function and misfolding. Clin. Chim. Acta 357 (2005) 168-172
18. Röcken C., Becker K., Fändrich M., Schroeckh V., Stix B., Rath T., et al. A Lys amyloidosis caused by compound heterozygosity in exon 2 (Thr70Asn) and exon 4 (Trp112Arg) of the lysozyme gene. Hum. Mutat. 27 (2006) 119-120
19. Booth D.R., Pepys M.B., and Hawkins P.N. A novel variant of human lysozyme (T70N) is common in the normal population. Hum. Mutat. 16 (2000) 180
20. Booth D.R., Sunde M., Bellotti V., Robinson C.V., Hutchinson W.L., Fraser P.E., et al. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 27 (1997) 787-793
21. Dumoulin M., Canet D., Last A.M., Pardon E., Archer D.B., Muyldermans S., et al. Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations. J. Mol. Biol. 25 (2005) 773-788
22. Kumita J.R., Johnson R.J., Alcocer M.J., Dumoulin M., Holmqvist F., McCammon M.G., et al. Impact of the native-state stability of human lysozyme variants on protein secretion by Pichia pastoris. FEBS J. 273 (2006) 711-720
23. Morozova-Roche L.A., Zurdo J., Spencer A., Noppe W., Receveur V., Archer D.B., et al. Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. J. Struct. Biol. 130 (2000) 339-351
24. De Felice F.G., Vieira M.N., Meirelles M.N., Morozova-Roche L.A., Dobson C.M., and Ferriera S.T. Formation of amyloid aggregates from human lysozyme and its disease-associated variants using hydrostatic pressure. FASEB J. 18 (2004) 1099-1101
25. 1H NMR studies of human lysozyme: Spectral assignment and comparison with hen lysozyme. Biochemistry 29 (1990) 7201-7214
26. Hooke S.D., Radford S.E., and Dobson C.M. The refolding of human lysozyme: A comparison with the structurally homologous hen lysozyme. Biochemistry 33 (1994) 5867-5876
27. Dumoulin, M., Kumita, J. & Dobson, C. M. (2006). Normal and aberrant biological self-assembly: Insights from studies of human lysozyme and its amyloidogenic variants. Accts Chem. Res. In press.
28. Canet D., Last A.M., Tito P., Sunde M., Spencer A., Archer D.B., et al. Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme. Nature Struct. Biol. 9 (2002) 308-315
29. Frare E., Polverino de Laureto P., Zurdo J., Dobson C.M., and Fontana A. A highly amyloidogenic region of hen lysozyme. J. Mol. Biol. 23 (2004) 1153-1165
30. Krebs M.R., Wilkins D.K., Chung E.W., Pitkeathly M.C., Chamberlain A.K., Zurdo J., et al. Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain. J. Mol. Biol. 14 (2000) 541-549
31. Tycko R. Progress towards a molecular-level structural understanding of amyloid fibrils. Curr. Opin. Struct. Biol. 14 (2004) 96-103
32. Sunde M., and Blake C. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Advan. Protein Chem. 50 (1997) 123-159
33. Ivanova M.I., Sawaya M.R., Gingery M., Attinger A., and Eisenberg D. An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril. Proc. Natl Acad. Sci. USA 101 (2004) 10584-10589
34. Nelson R., Sawaya M.R., Balbirnie M., Madsen A.O., Riekel C., Grothe R., and Eisenberg D. Structure of the cross-beta spine of amyloid-like fibrils. Nature 435 (2005) 773-778
35. Chamberlain A.K., MacPhee C.E., Zurdo J., Morozova-Roche L.A., Hill H.A., Dobson C.M., and Davis J.J. Ultrastructural organization of amyloid fibrils by atomic force microscopy. Biophys. J. 79 (2000) 3282-3293
36. Jiménez J.L., Guijarro J.I., Orlava E., Zurdo J., Dobson C.M., Sunde M., and Saibil H.R. Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J. 18 (1999) 815-821
37. Jiménez J.L., Nettleton E.J., Bouchard M., Robinson C.V., Dobson C.M., and Saibil H.R. The protofilament structure of insulin amyloid fibrils. Proc. Natl Acad. Sci. USA 99 (2002) 9196-9201
38. Bouchard M., Zurdo J., Nettleton E.J., Dobson C.M., and Robinson C.V. Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy. Protein Sci. 9 (2000) 1960-1967
39. Zurdo J., Guijarro J.I., Jiménez J.L., Saibil H.R., and Dobson C.M. Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain. J. Mol. Biol. 311 (2001) 325-340
40. Zurdo J., Guijarro J.I., and Dobson C.M. Preparation and characterization of purified amyloid fibrils. J. Am. Chem. Soc. 123 (2001) 8141-8142
41. Polverino de Laureto P., Frare E., Battaglia F., Mossuto M.F., Uversky V.N., and Fontana A. Protein dissection enhances the amyloidogenic properties of alpha-lactalbumin. FEBS J. 272 (2005) 2176-2188
42. Lansbury Jr. P.T., Costa P.R., Griffiths J.M., Simon E.J., Auger M., Halverson K.J., et al. Structural model for the beta-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide. Nature Struct. Biol. 2 (1995) 990-998
43. Jaroniec C.P., MacPhee C.E., Bajaj V.S., McMahon M.T., Dobson C.M., and Griffin R.G. High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy. Proc. Natl Acad. Sci. USA 101 (2004) 711-716
44. Ritter C., Maddelein M.L., Siemer A.B., Luhrs T., Ernst M., Meier B.H., et al. Correlation of structural elements and infectivity of the HET-s prion. Nature 435 (2005) 844-848
45. Kheterpal I., Zhou S., Cook K.D., and Wetzel R. Abeta amyloid fibrils possess a core structure highly resistant to hydrogen exchange. Proc. Natl Acad. Sci. USA 97 (2000) 13597-13601
46. Kheterpal I., Lashuel H.A., Hartley D.M., Walz T., Lansbury Jr. P.T., and Wetzel R. Abeta protofibrils possess a stable core structure resistant to hydrogen exchange. Biochemistry 42 (2003) 14092-14098
47. Hoshino M., Katou H., Hagihara Y., Hasegawa K., Naiki H., and Goto Y. Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange. Nature Struct. Biol. 9 (2002) 332-336
48. Carulla N., Caddy G.L., Hall D.R., Zurdo J., Gairi M., Feliz M., et al. Molecular recycling within amyloid fibrils. Nature 436 (2005) 554-558
49. Kheterpal I., Williams A., Murphy C., Bledsoe B., and Wetzel R. Structural features of the Abeta amyloid fibril elucidated by limited proteolysis. Biochemistry 40 (2001) 11757-11767
50. Miake H., Mizusawa H., Iwatsubo T., and Hasegawa M. Biochemical characterization of the core structure of alpha-synuclein filaments. J. Biol. Chem. 277 (2002) 19213-19219
51. Baxa U., Taylor K.L., Wall J.S., Simon M.N., Cheng N., Wickner R.B., and Steven A.C. Architecture of Ure2p prion filaments: the N-terminal domains form a central core fiber. J. Biol. Chem. 278 (2003) 43717-43727
52. Bousset L., Briki F., Doucet J., and Melki R. The native-like conformation of Ure2p in fibrils assembled under physiologically relevant conditions switches to an amyloid-like conformation upon heat-treatment of the fibrils. J. Struct. Biol. 141 (2003) 132-142
53. Polverino de Laureto P., Taddei N., Frare E., Capanni C., Costantini S., Zurdo J., et al. Protein aggregation and amyloid fibril formation by an SH3 domain probed by limited proteolysis. J. Mol. Biol. 334 (2003) 129-141
54. Fontana A., Polverino de Laureto P., De Filippis V., Scaramella E., and Zambonin M. Probing the partly folded states of proteins by limited proteolysis. Fold. Des. 2 (1997) R17-R26
55. Fontana A., Polverino de Laureto P., De Filippis V., Scaramella E., and Zambonin M. Limited proteolysis in the study of protein conformation. In: Sterchi E.E., and Stöcker W. (Eds). Proteolytic Enzymes: Tools and Targets (1999), Springer Verlag, Heidelberg 257-284
56. Hubbard S.J. The structural aspects of limited proteolysis of native proteins. Biochim. Biophys. Acta 1382 (1998) 191-206
57. Fontana A., Polverino de Laureto P., Spolaore B., Frare E., Picotti P., and Zambonin M. Probing protein structure by limited proteolysis. Acta Biochim. Pol. 51 (2004) 299-321
58. Li A., Sowder R.C., Henderson L.E., Moore S.P., Garfinkel D.J., and Fisher R.J. Chemical cleavage at aspartyl residues for protein identification. Anal. Chem. 15 (2001) 5395-5402
59. Malisauskas M., Zamotin V., Jass J., Noppe W., Dobson C.M., and Morozova-Roche L.A. Amyloid protofilaments from the calcium-binding protein equine lysozyme: formation of ring and linear structures depends on pH and metal ion concentration. J. Mol. Biol. 330 (2003) 879-890
60. Polverino de Laureto P., Frare E., Gottardo R., Van Dael H., and Fontana A. Partly folded states of members of the lysozyme/lactalbumin superfamily: a comparative study by circular dichroism spectroscopy and limited proteolysis. Protein Sci. 11 (2002) 2932-2946
61. Fruton J.S. The specificity and mechanism of pepsin action. Advan. Enzymol. Relat. Areas Mol. Biol. 33 (1970) 401-443
62. Fabian H., Choo L.P., Szendrei G.I., Jackson M., Halliday W.C., Otvos Jr. L., and Mantsch H.H. Infrared spectroscopic characterization of Alzheimer plaques. Appl. Spectrosc. 47 (1993) 1513-1518
63. Zandomeneghi G., Krebs M.R., McCammon M.G., and Fändrich M. FTIR reveals structural differences between native beta-sheet proteins and amyloid fibrils. Protein Sci. 13 (2004) 3314-3321
64. Krimm S., and Bandekar J. Vibrational spectroscopy and conformation of peptides, polypeptides and proteins. Advan. Protein Chem. 38 (1986) 181-364
65. Arrondo J.L., Muga A., Castresana J., and Goni F.M. Quantitative studies of the structure of proteins in solution by Fourier-transform infrared spectroscopy. Prog. Biophys. Mol. Biol. 59 (1993) 23-56
66. Barth A. The infrared absorption of amino acid side chains. Prog. Biophys. Mol. Biol. 74 (2000) 141-173
67. Haezebrouck P., Joniau M., Van Dael H., Hooke S.D., Woodruff N.D., and Dobson C.M. An equilibrium partially folded state of human lysozyme at low pH. J. Mol. Biol. 246 (1995) 382-387
68. Fink A.L. Protein aggregation: Folding aggregates, inclusion bodies and amyloid. Fold. Des. 3 (1998) R9-R23
69. Serpell L.C. Alzheimer's amyloid fibrils: Structure and assembly. Biochim. Biophys. Acta 1502 (2000) 16-30
70. Jiménez J.L., Tennent G., Pepys M., and Saibil H.R. Structural diversity of ex vivo amyloid fibrils studied by cryo-electron microscopy. J. Mol. Biol. 311 (2001) 241-247
71. von Bergen M., Barghorn S., Muller S.A., Rickardt M., Biernat J., Mandelkow E.M., et al. The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis. Biochemistry 45 (2006) 6446-6457
72. Kajava A.V., Baxa U., Wickner R.B., and Steven A.C. A model for Ure2p prion filaments and other amyloids: The parallel superplated β-structure. Proc. Natl Acad. Sci. USA 101 (2004) 7885-7890
73. Johnson R.J., Christodoulou J., Dumoulin M., Caddy G.L., Alcocer M.J., Murtagh G.J., et al. Rationalising lysozyme amyloidosis: Insights from the structure and solution dynamics of T70N lysozyme. J. Mol. Biol. 352 (2005) 823-836
74. Dumoulin M., Last A.M., Desmyter A., Decanniere K., Canet D., Larsson G., et al. A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. Nature 14 (2003) 783-788
75. Kelly J.W. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8 (1998) 101-106
76. Dobson C.M. Protein folding and diseases: A view from the first Horizon Symposium. Nature Rev. Drug Discov. 2 (2003) 154-160
77. Uversky V.N., and Fink A.L. Conformational constraints for amyloid fibrillation: The importance of being unfolded. Biochim. Biophys. Acta 1698 (2004) 131-153
78. Rochet J.C., and Lansbury Jr. P.T. Amyloid fibrillogenesis: Themes and variations. Curr. Opin. Struct. Biol. 10 (2000) 60-68
79. Jahn T.R., and Radford S.E. The Yin and Yang of protein folding. FEBS J. 272 (2005) 5962-5970
80. Baldwin A.J., Bader R., Christodoulou J., MacPhee C.E., Dobson C.M., and Barker P.D. Cytochrome display on amyloid fibrils. J. Am. Chem. Soc. 128 (2006) 2162-2163
81. Dobson C.M. Structural biology: Prying into prions. Nature 435 (2005) 747-749
82. López de la Paz M., and Serrano L. Sequence determinants of amyloid fibril formation. Proc. Natl Acad. Sci. USA 101 (2004) 87-92
83. Pawar A.P., Dubay K.F., Zurdo J., Chiti F., Vendruscolo M., and Dobson C.M. Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. J. Mol. Biol. 350 (2005) 379-392
84. Chiti F., and Dobson C.M. Protein misfolding, functional amyloid, and human disease. Ann. Rev. Biochem. 75 (2006) 333-366
85. Chung E.W., Nettleton E.J., Morgan C.J., Gross M., Miranker A., Radford S.E., et al. Hydrogen exchange properties of proteins in native and denatured states monitored by mass spectrometry and NMR. Protein Sci. 6 (1997) 1316-1324
86. Canfield R.E., Kamerman S., Sobel H.H., and Morgan F.J. Primary structure of lysozymes from man and goose. Nature New Biol. 232 (1971) 16-17
87. Gill S.G., and von Hippel P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182 (1989) 319-326
88. Byler D.M., and Susi H. Examination of the secondary structure of proteins by deconvolved FTIR spectra. Biopolymers 25 (1986) 469-487
89. Arrondo J.L., Castresana J., Valpuesta J.M., and Goni F.M. Structure and thermal denaturation of crystalline and noncrystalline cytochrome oxidase as studied by infrared spectroscopy. Biochemistry 33 (1994) 11650-11655
90. García-García J., Corbalan-Garcia S., and Gomez-Fernandez J.C. Effect of calcium and phosphatidic acid binding on the C2 domain of PKC alpha as studied by Fourier transform infrared spectroscopy. Biochemistry 38 (1999) 9667-9675
91. Blake C.C., Pulford W.C., and Artymiuk P.J. X-ray studies of water in crystals of lysozyme. J. Mol. Biol. 167 (1983) 693-723